Alloksys Life Sciences B.V.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Wageningen Netherlands (2005)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2011
NCT01416493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Alloksys Life Sciences BV . President